ERBB3 and neoplasm: However, as patients with gastric and esophageal cancer are increasingly being treated with neoadjuvant therapy, future studies should also examine the effects of neoadjuvant treatment by comparing the expression and predictive effects of different HERs, in particular HER3, in tumour tissue before and after treatment.